These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 23943362)
1. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade. Johnson JL; de Mejia EG Mol Nutr Food Res; 2013 Dec; 57(12):2112-27. PubMed ID: 23943362 [TBL] [Abstract][Full Text] [Related]
2. Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro. Johnson JL; Gonzalez de Mejia E Food Chem Toxicol; 2013 Oct; 60():83-91. PubMed ID: 23871783 [TBL] [Abstract][Full Text] [Related]
3. Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity. Johnson JL; Rupasinghe SG; Stefani F; Schuler MA; Gonzalez de Mejia E J Med Food; 2011 Apr; 14(4):325-33. PubMed ID: 21443429 [TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223 [TBL] [Abstract][Full Text] [Related]
5. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935 [TBL] [Abstract][Full Text] [Related]
6. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells. Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460 [TBL] [Abstract][Full Text] [Related]
7. The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells. Yin JQ; Wen L; Wu LC; Gao ZH; Huang G; Wang J; Zou CY; Tan PX; Yong BC; Jia Q; Shen JN Toxicol Lett; 2013 Apr; 218(2):129-36. PubMed ID: 23164673 [TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615 [TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway. Cao L; Liu J; Zhang L; Xiao X; Li W Oncol Rep; 2016 Oct; 36(4):2245-51. PubMed ID: 27572503 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Yoshino Y; Ishioka C Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722 [TBL] [Abstract][Full Text] [Related]
11. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Srivastava SK; Singh SV Carcinogenesis; 2004 Sep; 25(9):1701-9. PubMed ID: 15117814 [TBL] [Abstract][Full Text] [Related]
12. Sporamin induces apoptosis and inhibits NF-κB activation in human pancreatic cancer cells. Qian C; Chen X; Qi Y; Zhong S; Gao X; Zheng W; Mao Z; Yao J Tumour Biol; 2017 Jul; 39(7):1010428317706917. PubMed ID: 28714369 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3β (GSK-3β) phosphorylation inhibitors. Zhao P; Li Y; Gao G; Wang S; Yan Y; Zhan X; Liu Z; Mao Z; Chen S; Wang L Eur J Med Chem; 2014 Oct; 86():165-74. PubMed ID: 25151579 [TBL] [Abstract][Full Text] [Related]
14. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer. Wilson W; Baldwin AS Cancer Res; 2008 Oct; 68(19):8156-63. PubMed ID: 18829575 [TBL] [Abstract][Full Text] [Related]
15. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells. Wu DG; Yu P; Li JW; Jiang P; Sun J; Wang HZ; Zhang LD; Wen MB; Bie P Toxicol Lett; 2014 Jan; 224(1):157-64. PubMed ID: 24148603 [TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy. Mamaghani S; Patel S; Hedley DW BMC Cancer; 2009 Apr; 9():132. PubMed ID: 19405981 [TBL] [Abstract][Full Text] [Related]
17. The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells. Guzmán EA; Maers K; Roberts J; Kemami-Wangun HV; Harmody D; Wright AE Invest New Drugs; 2015 Feb; 33(1):86-94. PubMed ID: 25416019 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells. Nambiar D; Prajapati V; Agarwal R; Singh RP Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268 [TBL] [Abstract][Full Text] [Related]
19. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells. Veeraraghavan J; Natarajan M; Lagisetty P; Awasthi V; Herman TS; Aravindan N Pancreas; 2011 Oct; 40(7):1107-19. PubMed ID: 21697760 [TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma. Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]